Rex, John H.
F2G,
United Kingdom
2025 Rank: 135787
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
General & Internal Medicine
Rank in SubField 1: 2635 out of 217955 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 135787 | 148145 |
| Total Cites | 793 | 842 |
| H-index | 13 | 14 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 40 | 40 |
| Total Cites to Single+First Authored Papers | 52 | 56 |
| Number of Single+First+Last Authored Papers | 103 | 103 |
| Total Cites to Single+First+Last Authored Papers | 257 | 267 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 713 | 739 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.14 |
| Self-Citation Percentage |
5.82%
|
|
Rex, John H.
F2G Limited,
United Kingdom
2022 Rank: 62741
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1493 out of 175943 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 62741 | 60099 |
| Total Cites | 865 | 929 |
| H-index | 15 | 15 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 6 | 7 |
| Number of Single+First Authored Papers | 39 | 39 |
| Total Cites to Single+First Authored Papers | 98 | 108 |
| Number of Single+First+Last Authored Papers | 101 | 101 |
| Total Cites to Single+First+Last Authored Papers | 363 | 381 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 742 | 776 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.20 |
| Self-Citation Percentage |
6.89%
|
|
Rex, John H.
University of Texas Medical School at Houston,
United States
2021 Rank: 50558
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
General & Internal Medicine
Rank in SubField 1: 1151 out of 165244 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 50558 | 55101 |
| Total Cites | 1317 | 1401 |
| H-index | 18 | 19 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 11 | 11 |
| Number of Single+First Authored Papers | 43 | 43 |
| Total Cites to Single+First Authored Papers | 182 | 189 |
| Number of Single+First+Last Authored Papers | 108 | 108 |
| Total Cites to Single+First+Last Authored Papers | 567 | 584 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1117 | 1165 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.20 |
| Self-Citation Percentage |
6.00%
|
|
Rex, John H.
F2G Limited,
United Kingdom
2020 Rank: 61947
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1313 out of 134369 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 61947 | 69143 |
| Total Cites | 761 | 782 |
| H-index | 14 | 14 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 10 | 10 |
| Number of Single+First Authored Papers | 43 | 43 |
| Total Cites to Single+First Authored Papers | 113 | 116 |
| Number of Single+First+Last Authored Papers | 103 | 103 |
| Total Cites to Single+First+Last Authored Papers | 324 | 332 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 629 | 643 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.22 |
| Self-Citation Percentage |
2.69%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.